tirzepatide cardiovascular SURPASS-CVOT Published: Large Trial Confirms CVD Efficacy of Tirzepatide demonstrates cardiovascular protection in

Eggert, S

Ongoing lifestyle modification support

Mean age: 53.1 years (median 54) Sex: 86% female Race: 79% White, 13% Black or African American, 6% Hispanic, and 1% Asian Treatment duration: 81% had used semaglutide for at least 4 months, and 30% for more than one year Participants were asked to recall their experiences before starting semaglutide and to report their current experiences while using it

Change the injection site every week

Yes, semaglutide may help reduce chronic inflammation by improving insulin sensitivity, lowering visceral fat, stabilizing blood sugar levels, and influencing inflammatory signaling pathways linked to metabolic health

This premium IV contains: Vitamin C, B1, B2, B3, B5, B6, Magnesium Chloride, Zinc, Manganese, Copper, Selenium